The first ever Global AMR Innovators Conference (GAMRIC) will take place from 1-3 October now in London, UK. The location was changed with the hope of maximising global participation from all continents which is made easier with London’s central location and many travel options.

Abstract submission and registration are now open! Be sure to submit your original abstract to be included in the programme before the deadline on 13 June. And with only 300 onsite tickets available, early registration is recommended to guarantee your place.

Learn more on how to submit your abstract and secure your seat at this innovative conference on the website.

Science and Research

The ESCMID Green Team drives sustainability through collaboration, education, advocacy and awareness, resource sharing and reducing the environmental impact of ESCMID activities. The team is looking for passionate members to join them and their initiatives to create new activities and projects together. You can check the ESCMID Sustainability webpage for more information. Apply before the deadline on 13 May 2025!

ESCMID Study Groups offer a lot of opportunity for ESCMID members to get involved including access to special funding for their research projects. The next call for Study Group Research Grants will open soon on 21 May 2025. Membership in a study group is free for all ESCMID members so don’t miss out on this opportunity to get your innovative research project funded with the help and support of ESCMID.

Education

The landscape of treating drug-resistant tuberculosis (TB) is evolving rapidly with new drugs and regimens. However, the diagnostic pipeline is struggling to keep pace. The World Health Organization (WHO) has recently endorsed targeted Next Generation Sequencing (tNGS) as a molecular tool for obtaining rapid genotypic data to guide clinical management. Understanding its potential and limitations is crucial for effective implementation.

Registration for this course is open. Attendance Grant applications are also offered so see if you are eligible and apply today.

Join leading experts for three intensive days of interactive, hands-on training where you will master cutting-edge rapid diagnostics and antimicrobial susceptibility testing (AST) techniques essential for managing bloodstream infections (BSIs). Through practical exercises, real-world case discussions, and personalised feedback, you'll gain the skills to implement innovative testing methods in your clinical practice, improving patient outcomes and supporting antimicrobial stewardship. This course will equip you with the knowledge and confidence to lead the future of BSI management.

Congress & Events

Late-breaker abstract submission for the 14th edition of the International Meeting on Microbial Epidemiological Markers (IMMEM XIV) is now open. Don’t miss this opportunity to join in the programme, submit your abstract before the deadline on 23 May 2025.

Learn more about the abstract topics that are being accepted and get information on the programme and additional activities on the website.

Are you already missing your time in Vienna? Relive the excitement with online access to ESCMID Global 2025. You can watch all scientific sessions via the replay feature, and you can even claim certificates of attendance and CME points by catching up on the sessions you missed. Registration is even still open if you want to join now online and watch at your own pace. All content will be available until October, so you have plenty of time to enjoy getting caught up on the cutting-edge science that was presented at ESCMID Global.

Guidelines and Journals

In this first-ever Communicable and Breakpoints crossover episode, hosts Angela Huttner and Erin McCreary are joined by SNAP trial investigators Steven Tong and Jashua Davis to discuss the results that were shared at ESCMID Global 2025. Don’t miss this momentous collaboration between CMI Communications and the Society of Infectious Diseases Pharmacists.

The draft document "The Care Continuum of Patients with Influenza in the Post-COVID-19 Era: A Position Paper by the ESCMID Guideline Panel for Influenza" is now available for public consultation.

ESCMID members wishing to participate can review the rules and requirements for commenting on our website. The deadline to provide feedback on the draft manuscript is 22 May 2025.

Long-term sequelae post-hospitalization for respiratory syncytial virus versus Omicron SARS-CoV-2 or influenza in adults and children: a retrospective cohort study

Are Bactericidal Antibiotics Necessary to Effectively Treat Bloodstream Infections?

ESCAIDE call for abstracts closing on 14 May